Tetragenex Pharmaceuticals, Inc.
11
10/26/2010
Yes
| Repeat, CLOSED |
Assigned to: Robert E. Grossman Chapter 11 Voluntary Asset Debtor disposition: Discharge Not Applicable |
|
Debtor Tetragenex Pharmaceuticals, Inc.
6901 Jericho Turnpike Suite 221 Jericho, NY 11791 NASSAU-NY Tax ID / EIN: 22-3781895 fka Innapharma, Inc. |
represented by |
Paul Rachmuth
Gersten Savage LLP 600 Lexington Avenue New York, NY 10022 212-752-9700 Fax : 212-980-5192 Email: prachmuth@gerstensavage.com |
U.S. Trustee United States Trustee
Long Island Federal Courthouse 560 Federal Plaza - Room 560 Central Islip, NY 11722-4437 (631) 715-7800 |
| Date Filed | # | Docket Text |
|---|---|---|
| 01/18/2012 | Bankruptcy Case Closed (ssw) (Entered: 01/18/2012) | |
| 01/04/2012 | ENTERED IN ERROR- Bankruptcy Case Closed (ssw) Modified on 1/4/2012 (ssw). (Entered: 01/04/2012) | |
| 01/03/2012 | 46 | Final Decree Chapter 11 Signed on 1/3/2012 ; This Chapter 11 Bankruptcy Case be closed (RE: Related Document 45Motion for Final Decree ) (ssw) (Entered: 01/04/2012) |
| 06/30/2011 | 45 | Application for Final DecreeFiled by Paul Rachmuth on behalf of Tetragenex Pharmaceuticals, Inc.. (Rachmuth, Paul) Modified on 7/1/2011 for clarification. (ssw). (Entered: 06/30/2011) |
| 01/28/2011 | 44 | LetterNotice of Effective DateFiled by Paul Rachmuth on behalf of Tetragenex Pharmaceuticals, Inc. (RE: related document(s) 40Amended Chapter 11 Plan filed by Debtor Tetragenex Pharmaceuticals, Inc.) (Rachmuth, Paul) (Entered: 01/28/2011) |
| 01/20/2011 | 43 | Monthly Operating Report for Filing Period December, 2010 Filed by Paul Rachmuth on behalf of Tetragenex Pharmaceuticals, Inc. (Attachments: 1Signature Page 2Exhibit 1 3Exhibit 2 4Exhibit 3 5Exhibit 4 6Exhibit 5 7Exhibit 6 8Exhibit 7 9Exhibit 8) (Rachmuth, Paul) (Entered: 01/20/2011) |
| 01/08/2011 | 42 | BNC Certificate of Mailing with Notice of Order Confirming Ch 11 Plan Service Date 01/08/2011. (Admin.) (Entered: 01/09/2011) |
| 01/06/2011 | 41 | Order Approving the Disclosure Statement and Confirming Amended Prepackaged Plan of Reorganization of Tetragenex Pharmaceuticals, Inc. (RE: related document(s) 3Motion to Consider approval of Disclosure Statement and Confirmation of Plan 40Amended Chapter 11 Plan filed by Debtor Tetragenex Pharmaceuticals, Inc.). Final Decree Due on 4/6/2011. Signed on 1/6/2011. (ssw) (Entered: 01/06/2011) |
| 01/06/2011 | 40 | Second Amended Chapter 11 Plan As Confirmed, Dated December 16, 2010 Signed by Martin Schacker Filed by Paul Rachmuth on behalf of Tetragenex Pharmaceuticals, Inc. (RE: related document(s) 31Chapter 11 Plan filed by Debtor Tetragenex Pharmaceuticals, Inc.). (Rachmuth, Paul) (Entered: 01/06/2011) |
| 01/06/2011 | 39 | ENTERED IN ERROR (AS PER CHAMBER'S INSTRUCTION ); SEE CORRECTED ENTRY BELOW - Second Amended Chapter 11 Plan Dated December 16, 2010 Martin Schacker Filed by Paul Rachmuth on behalf of Tetragenex Pharmaceuticals, Inc. (RE: related document(s) 31Chapter 11 Plan filed by Debtor Tetragenex Pharmaceuticals, Inc.). (Rachmuth, Paul) Modified on 1/6/2011 (ssw). (Entered: 01/06/2011) |